Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mitolactol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 71 for your search:
Start Over
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 14 to 75
Sponsor: NCI
Protocol IDs: EST-3377
Phase III Chemotherapy with Adriamycin/Dibromodulcitol vs Adriamycin Alone for Resistant Advanced Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: postmenopausal
Sponsor:
Protocol IDs: MAYO-793251, NCCTG-793251
Radiation Therapy in Treating Patients With Brain Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: Other
Protocol IDs: EORTC-26882, NCT00002620
AC (ADR/CTX) Followed by CMFP (CTX/MTX/5-FU/PRED) or CMFP (DBD/MTX/5-FU/PRED) Both Alternating with AC for Metastatic Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-D78-017-074
L-ASP/PRED/VCR/ARA-C/ADR, DBD or CTX Plus Intrathecal Prophylactic MTX/CF for Marrow Relapse in Children with ALL/AUL LEUKEMIA
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-142A
L-ASP/PRED/VCR/ARA-C/ADR, DBD OR CTX, Plus Intrathecal ARA-C/HC/MTX/CF for Marrow and CNS Relapse in Children with ALL/AUL
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-142B
Phase III Induction with DAVTH (DBD/ADR/VCR/TMX/HAL) plus Randomized Maintenance for Metastatic or Recurrent Breast Cancer in Men and Women
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2181
Phase III Chemotherapy with DAVcH (DBD/ADR/VCR/HAL) vs TsAVbH (Thiotepa/ADR/VBL/HAL) for Disseminated or Recurrent Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-6181
Phase III Induction with DAVTH (DBD/ADR/VCR/TMX/FXM) Followed by Cyclic Therapy with DAVTH and CMFP (CTX/5-FU/MTX/PRED) for Recurrent Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-048-184, WCCC-CO-7814
Phase III Comparison of MTX plus 5-FU with CTX or with Dibromodulcitol for Stage II-III Adenocarcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 80
Sponsor:
Protocol IDs: CENOG-7534
Phase III Chemotherapy with ADR/DBD/TMX vs MITO/TMX vs MITO/TMX/FXM after Prior Systemic Therapy for Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1179, NCI-D79-048-089
Phase I-II Chemotherapy with Dibromodulcitol/Hexamethylmelamine for Carcinoma of the Breast Refractory to ADR, CTX or MTX
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-77PBRE0201, SEG-77BREP20
Phase I/II Chemotherapy with Intermittent Intravenous DBD for Refractory Stage III/IV Malignant Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: NCI-D80-035-403
Phase I/II Chemotherapy with Dibromodulcitol for Pediatric Solid Tumors and CNS Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-8070
Phase I/II Combination Chemotherapy with DBD/DTIC/ACT-D for Disseminated Malignant Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-38380
Phase I/II Chemotherapy with L-PAM/DBD plus Priming CTX and Autologous Bone Marrow Rescue for Metastatic Malignant Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-50283, NCI-T83-1011C, T83-1011
Phase I/II Cyclic Combination Chemotherapy with CAF (CTX/ADR/5-FU), D(DHAD)V (DBD/DHAD/VCR), and TsAVb (Thiotepa/ADR/VBL) in Women with Metastatic or Recurrent Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-8313, NCI-T84-0244D, T84-0244
Phase I/II Cyclic Combination Chemotherapy with CAF (CTX/ADR/5-FU) and TsAVb (Thiotepa/ADR/VBL) in Women with Metastatic or Recurrent Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PB-184, EST-P-B184
Phase I/II Dose-Seeking Studies with Various Combinations of DBD, AMSA and VP-16 for Advanced Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-800302
Phase II Pilot Chemotherapy with ADR, DBD, and Mitomycin-C for Stage IV Breast Cancer Patients Refractory to CMF
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7825
Start Over